The former president of an energy company who was sentenced to 78 months in prison after pleading guilty to honest services fraud conspiracy and other offenses lost his Fifth Circuit appeal ...

A former pharmaceutical executive traded on nonpublic information about an antipsychotic drug’s development, avoiding $1.3 ...

Demos, a medical doctor who was the Vice President of Drug Safety and Pharmacovigilance and member of the drug label team at ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...

VP at Acadia Pharmaceuticals, pled guilty to insider trading, avoiding a $1.3M loss by illicitly selling shares ahead of a ...

The former CEO of Acadia Pharmaceuticals Inc., headquartered in Sorrento Valley, pleaded guilty Friday to insider trading.

On Wednesday, state officials joined local leaders and private sector partners to celebrate the groundbreaking of Pacific ...

The former vice president of a Carmel Valley pharmaceutical company pleaded guilty Friday to a federal securities fraud count ...

Currently, George Weston has an average volume of 122.4K. Based on the recent corporate insider activity of 139 insiders, corporate insider sentiment is positive on the stock. This means that over ...

Scotiabank analyst John Zamparo downgraded George Weston (WNGRF) to Sector Perform from Outperform with a price target of C$241, up from C$240. The stock has outperformed year-to-date and while ...